Central Trust Company’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,196
Closed -$34K 1354
2018
Q1
$34K Sell
2,196
-5,672
-72% -$94.7K ﹤0.01% 742
2017
Q4
$128K Buy
+7,868
New +$152K 0.01% 542
2015
Q3
Sell
-200
Closed -$7K 1261
2015
Q2
$7K Hold
200
﹤0.01% 1077
2015
Q1
$7K Hold
200
﹤0.01% 1049
2014
Q4
$7K Sell
200
-270
-57% -$9.52K ﹤0.01% 1048
2014
Q3
$17K Buy
470
+270
+135% +$10.2K ﹤0.01% 882
2014
Q2
$8K Hold
200
﹤0.01% 1007
2014
Q1
$8K Hold
200
﹤0.01% 999
2013
Q4
$7K Hold
200
﹤0.01% 1001
2013
Q3
$6K Hold
200
﹤0.01% 1034
2013
Q2
$7K Buy
+200
New +$6.19K ﹤0.01% 976

Other funds holding DBD

Central Trust Company's DBD Position: Q2 2018 in Review

Central Trust Company sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2018, closing a stake of 2,196 shares — an estimated $34K sold.

Central Trust Company first reported a position in DBD in Q2 2013 and held it in 11 quarters. The position peaked at $128K in Q4 2017. 233 funds tracked by Wall St. Rank hold DBD as of Q2 2018.

  • Central Trust Company reported no remaining Diebold Nixdorf Incorporated position as of Q2 2018 after selling out during the quarter.
  • Central Trust Company sold 2,196 Diebold Nixdorf Incorporated shares in Q2 2018, an estimated $34K.
  • Central Trust Company first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 11 quarters.
  • Central Trust Company's Diebold Nixdorf Incorporated position peaked at $128K in Q4 2017.
  • 233 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2018.

Based on Central Trust Company's 13F filing for Q2 2018, filed 9 Jul 2018.